Table 2.
VEXUS score improving | VEXUS score no change | VEXUS score worsening | p value | |
---|---|---|---|---|
AKI | 0.003* | |||
Resolving | 20 (87%) | 3 (13%) | 0 | |
Not resolving | 2 (28.6%) | 3 (42.9%) | 2 (28.6%) | |
Fluid balance as | ||||
Decreasing | 17 (89.5%) | 2 (10.5%) | 0 | 0.006* |
Increasing | 3 (33.3%) | 4 (44.4%) | 2 (22.2%) | |
Fluid balance in liters day 2 | 0.20 ± 1.24 | 1.67±1.03 | 1.00 ± 0.00 | 0.03 |
CVP | 0.15 | |||
Normalized | 8 (88.9%) | 0 | 1 (11.1%) | |
Not normalized | 12 (63.2%) | 6 (31.6%) | 1 (5.3%) | |
LVF | 0.65 | |||
Normal | 15 (78.9%) | 3 (15.8%) | 1 (5.3%) | |
Reduced | 7 (63.6%) | 3 (27.3%) | 1 (9.1%) | |
RVF | 0.19 | |||
Normal | 16 (84.2%) | 2 (10.5%) | 1 (5.3%) | |
Reduced | 6 (54.5%) | 4 (36.4%) | 1 (9.1%) |
Statistical test used the Fischer exact test for categorical outcomes and the Kruskal–Wallis test for fluid balance in liters. *p value less than 0.05 considered statistically significant. CVP, central venous pressure; LVF, left ventricular function; RVF, right ventricular function